Targeting of MCL-1 kills MYC-driven mouse and human lymphomas even when they bear mutations in <i>p53</i>Gemma L. Kelly, Andreas Strasser|Genes & Development|2014Cited by 169
Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer CellsZilu Wang, Andreas Strasser, Matteo Burigotto et al.|Cancer Discovery|2023Cited by 91
EBV BCL-2 homologue BHRF1 drives chemoresistance and lymphomagenesis by inhibiting multiple cellular pro-apoptotic proteinsLeah Fitzsimmons, Gemma L. Kelly|Cell Death and Differentiation|2019Cited by 61
Supplementary Data Figure S27 from Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer CellsZilu Wang, Andreas Strasser, Matteo Burigotto et al.|Unknown|2024Cited by 0
Supplementary Data Figure S21 from Loss-of-Function but Not Gain-of-Function Properties of Mutant TP53 Are Critical for the Proliferation, Survival, and Metastasis of a Broad Range of Cancer CellsZilu Wang, Andreas Strasser, Matteo Burigotto et al.|Unknown|2024Cited by 0